Regeneron Pharmaceuticals (REGN)
(Delayed Data from NSDQ)
$1,050.86 USD
-18.30 (-1.71%)
Updated Jun 27, 2024 04:00 PM ET
After-Market: $1,050.86 0.00 (0.00%) 4:38 PM ET
3-Hold of 5 3
C Value D Growth D Momentum D VGM
Brokerage Reports
Regeneron Pharmaceuticals, Inc. [REGN]
Reports for Purchase
Showing records 581 - 593 ( 593 total )
Company: Regeneron Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
Company: Regeneron Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
Company: Regeneron Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
Company: Regeneron Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
Company: Regeneron Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
Company: Regeneron Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
Company: Regeneron Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
Company: Regeneron Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
Company: Regeneron Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
Biotechnology / Biopharmaceuticals -Preview of Gout Abstracts at the Upcoming ACR
Provider: WEDBUSH SECURITIES INC.
Analyst: XU Y